Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endocarditis, Bacterial | 2 | 2018 | 436 | 0.890 |
Why?
|
| Legionellosis | 1 | 2017 | 11 | 0.570 |
Why?
|
| Legionella | 1 | 2017 | 27 | 0.570 |
Why?
|
| Endocarditis | 2 | 2018 | 348 | 0.540 |
Why?
|
| Needs Assessment | 1 | 2018 | 1139 | 0.410 |
Why?
|
| Physicians, Primary Care | 1 | 2018 | 623 | 0.390 |
Why?
|
| Accidental Falls | 1 | 2018 | 1068 | 0.360 |
Why?
|
| Primary Health Care | 1 | 2018 | 4687 | 0.200 |
Why?
|
| Psittacosis | 1 | 2017 | 4 | 0.150 |
Why?
|
| Bartonella Infections | 1 | 2017 | 21 | 0.140 |
Why?
|
| Q Fever | 1 | 2017 | 38 | 0.140 |
Why?
|
| Immunocompromised Host | 1 | 2001 | 858 | 0.130 |
Why?
|
| Outpatients | 1 | 2018 | 1597 | 0.090 |
Why?
|
| Fever of Unknown Origin | 1 | 1988 | 94 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2001 | 2781 | 0.080 |
Why?
|
| Inpatients | 1 | 2018 | 2548 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2018 | 8633 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 3688 | 0.070 |
Why?
|
| Staphylococcus aureus | 2 | 2013 | 1457 | 0.060 |
Why?
|
| Hemangioma, Capillary | 1 | 2003 | 64 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2018 | 4793 | 0.050 |
Why?
|
| Doxycycline | 1 | 2003 | 344 | 0.050 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2005 | 587 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2005 | 1391 | 0.030 |
Why?
|
| Antibodies, Heterophile | 1 | 1976 | 128 | 0.030 |
Why?
|
| Infectious Mononucleosis | 1 | 1976 | 133 | 0.030 |
Why?
|
| Ampicillin | 2 | 1974 | 136 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 5 | 2005 | 7406 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2003 | 2048 | 0.030 |
Why?
|
| Humans | 15 | 2018 | 761596 | 0.030 |
Why?
|
| Cephalothin | 4 | 1976 | 28 | 0.030 |
Why?
|
| Amino Sugars | 1 | 1972 | 39 | 0.030 |
Why?
|
| Pseudomonas | 1 | 1972 | 124 | 0.020 |
Why?
|
| Penicillins | 2 | 1976 | 402 | 0.020 |
Why?
|
| Gentamicins | 1 | 1972 | 243 | 0.020 |
Why?
|
| Probenecid | 3 | 1975 | 73 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 1972 | 825 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 169310 | 0.020 |
Why?
|
| Connective Tissue Diseases | 1 | 1988 | 285 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1976 | 3156 | 0.020 |
Why?
|
| Lung | 1 | 2003 | 10002 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 4 | 1976 | 1936 | 0.010 |
Why?
|
| Male | 9 | 2018 | 360846 | 0.010 |
Why?
|
| Bacteria | 3 | 2005 | 2199 | 0.010 |
Why?
|
| Linear Models | 1 | 2013 | 5872 | 0.010 |
Why?
|
| Hospitals, Community | 1 | 2005 | 365 | 0.010 |
Why?
|
| Blood Coagulation | 3 | 1979 | 1154 | 0.010 |
Why?
|
| Fibrin | 2 | 1975 | 507 | 0.010 |
Why?
|
| Oxacillin | 3 | 1976 | 41 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2003 | 592 | 0.010 |
Why?
|
| Endothelium | 1 | 2003 | 765 | 0.010 |
Why?
|
| Female | 3 | 2018 | 392705 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 13381 | 0.010 |
Why?
|
| Leprosy | 1 | 1979 | 126 | 0.010 |
Why?
|
| Drug Utilization | 1 | 2005 | 1188 | 0.010 |
Why?
|
| Haemophilus influenzae | 2 | 1976 | 178 | 0.010 |
Why?
|
| Staphylococcus | 2 | 1975 | 154 | 0.010 |
Why?
|
| Drug Costs | 1 | 2005 | 1183 | 0.010 |
Why?
|
| Cloxacillin | 1 | 1976 | 5 | 0.010 |
Why?
|
| Phlebitis | 1 | 1976 | 35 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18399 | 0.010 |
Why?
|
| Horses | 1 | 1976 | 300 | 0.010 |
Why?
|
| Cephalosporins | 2 | 1974 | 198 | 0.010 |
Why?
|
| Lincomycin | 1 | 1975 | 5 | 0.010 |
Why?
|
| Penicillin G | 1 | 1975 | 40 | 0.010 |
Why?
|
| Nafcillin | 1 | 1975 | 23 | 0.010 |
Why?
|
| Clindamycin | 1 | 1975 | 139 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 21355 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2005 | 2220 | 0.010 |
Why?
|
| Penicillin Resistance | 1 | 1974 | 74 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1976 | 957 | 0.010 |
Why?
|
| Collodion | 1 | 1973 | 34 | 0.010 |
Why?
|
| Sheep | 1 | 1976 | 1440 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2005 | 5247 | 0.010 |
Why?
|
| Streptococcus | 1 | 1974 | 198 | 0.010 |
Why?
|
| Hospitalization | 1 | 2013 | 10721 | 0.010 |
Why?
|
| Proteus | 1 | 1972 | 11 | 0.010 |
Why?
|
| Escherichia | 1 | 1972 | 7 | 0.010 |
Why?
|
| Enterobacteriaceae | 1 | 1974 | 161 | 0.010 |
Why?
|
| Amines | 1 | 1974 | 281 | 0.010 |
Why?
|
| Acinetobacter | 1 | 1972 | 39 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 2 | 1976 | 730 | 0.010 |
Why?
|
| Boston | 1 | 2005 | 9327 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 1973 | 366 | 0.010 |
Why?
|
| Diuretics | 1 | 1975 | 610 | 0.010 |
Why?
|
| Glycosides | 1 | 1972 | 100 | 0.010 |
Why?
|
| Neisseria gonorrhoeae | 1 | 1974 | 239 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 1976 | 1078 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2005 | 14608 | 0.000 |
Why?
|
| Adult | 8 | 2005 | 221210 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1974 | 4021 | 0.000 |
Why?
|
| Protein Binding | 2 | 1976 | 9353 | 0.000 |
Why?
|
| United States | 1 | 2013 | 72340 | 0.000 |
Why?
|
| Bile | 2 | 1975 | 298 | 0.000 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1972 | 1277 | 0.000 |
Why?
|
| Kidney | 2 | 1975 | 7048 | 0.000 |
Why?
|
| Liver | 2 | 1975 | 7528 | 0.000 |
Why?
|
| Portal Vein | 2 | 1975 | 431 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2005 | 41495 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1976 | 9319 | 0.000 |
Why?
|
| Dogs | 2 | 1975 | 3839 | 0.000 |
Why?
|
| Immunosorbent Techniques | 1 | 1979 | 175 | 0.000 |
Why?
|
| Neoplasms | 1 | 1988 | 22173 | 0.000 |
Why?
|
| Prothrombin Time | 1 | 1979 | 117 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1979 | 646 | 0.000 |
Why?
|
| Rabbits | 2 | 1975 | 4772 | 0.000 |
Why?
|
| Time Factors | 2 | 1976 | 39969 | 0.000 |
Why?
|
| Thromboplastin | 1 | 1979 | 286 | 0.000 |
Why?
|
| Thrombin | 1 | 1979 | 591 | 0.000 |
Why?
|
| Buffers | 1 | 1976 | 146 | 0.000 |
Why?
|
| Proteus mirabilis | 1 | 1976 | 24 | 0.000 |
Why?
|
| Chromium Radioisotopes | 1 | 1975 | 34 | 0.000 |
Why?
|
| Lymph | 1 | 1975 | 77 | 0.000 |
Why?
|
| Hepatic Veins | 1 | 1975 | 112 | 0.000 |
Why?
|
| Streptomycin | 1 | 1974 | 69 | 0.000 |
Why?
|
| Biliary Tract Diseases | 1 | 1975 | 159 | 0.000 |
Why?
|
| Kanamycin | 1 | 1974 | 63 | 0.000 |
Why?
|
| Cephaloridine | 1 | 1973 | 5 | 0.000 |
Why?
|
| Isoxazoles | 1 | 1976 | 232 | 0.000 |
Why?
|
| Cephalexin | 1 | 1973 | 37 | 0.000 |
Why?
|
| Culture Media | 1 | 1976 | 897 | 0.000 |
Why?
|
| Chemistry | 1 | 1973 | 347 | 0.000 |
Why?
|
| Animals | 5 | 1976 | 168475 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1973 | 507 | 0.000 |
Why?
|
| Thiadiazoles | 1 | 1973 | 63 | 0.000 |
Why?
|
| Streptococcus pyogenes | 1 | 1976 | 292 | 0.000 |
Why?
|
| Adsorption | 1 | 1973 | 197 | 0.000 |
Why?
|
| Filtration | 1 | 1973 | 228 | 0.000 |
Why?
|
| Sulfides | 1 | 1973 | 169 | 0.000 |
Why?
|
| Half-Life | 1 | 1973 | 651 | 0.000 |
Why?
|
| Injections, Intramuscular | 1 | 1973 | 554 | 0.000 |
Why?
|
| Biological Assay | 1 | 1975 | 626 | 0.000 |
Why?
|
| Kidney Tubules | 1 | 1974 | 449 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1974 | 1379 | 0.000 |
Why?
|
| Blood Flow Velocity | 1 | 1975 | 1371 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1973 | 2186 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1976 | 1173 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1973 | 3076 | 0.000 |
Why?
|
| Tetrazoles | 1 | 1973 | 909 | 0.000 |
Why?
|
| Glucose | 1 | 1976 | 4347 | 0.000 |
Why?
|
| Middle Aged | 1 | 1974 | 220921 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1973 | 8002 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1975 | 18255 | 0.000 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_